ACE Inhibitor Prevents LVEF Decline After Breast Cancer Drugs ACE Inhibitor Prevents LVEF Decline After Breast Cancer Drugs

For women with HER2-positive early breast cancer, concurrent therapy with ACE inhibitor lisinopril can help to prevent a decline in left-ventricular ejection fraction (LVEF).Medscape Medical News

Source: Medscape Hematology-Oncology Headlines - June 8, 2021 Category: Cancer & Oncology Tags: Cardiology News Source Type: news